Cargando…

Evaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast Cancer

Few studies have addressed the risk of recurrence by assessing proliferation markers in lymph node metastasis from breast cancer. Here, we aimed to examine Ki-67 expression and mitotic count in lymph nodes in comparison with primary tumors. A cohort of node positive breast cancer (n = 168) was studi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aziz, Sura, Wik, Elisabeth, Knutsvik, Gøril, Klingen, Tor Audun, Chen, Ying, Davidsen, Benedicte, Aas, Hans, Aas, Turid, Akslen, Lars A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783103/ https://www.ncbi.nlm.nih.gov/pubmed/26954367 http://dx.doi.org/10.1371/journal.pone.0150979

Ejemplares similares

Extra-nodal extension is a significant prognostic factor in lymph node positive breast cancer
por: Aziz, Sura, et al.
Publicado: (2017)

Tumor‐associated lymphocytes and macrophages are related to stromal elastosis and vascular invasion in breast cancer
por: Chen, Ying, et al.
Publicado: (2021)

CD47 and CD68 expression in breast cancer is associated with tumor‐infiltrating lymphocytes, blood vessel invasion, detection mode, and prognosis
por: Chen, Ying, et al.
Publicado: (2023)

Breast cancer stromal elastosis is associated with mammography screening detection, low Ki67 expression and favourable prognosis in a population-based study
por: Chen, Ying, et al.
Publicado: (2014)

Evaluation of Ki67 Expression across Distinct Categories of Breast Cancer Specimens: A Population-Based Study of Matched Surgical Specimens, Core Needle Biopsies and Tissue Microarrays
por: Knutsvik, Gøril, et al.
Publicado: (2014)

Fibulin-2 expression associates with vascular invasion and patient survival in breast cancer
por: Klingen, Tor A., et al.
Publicado: (2021)

Stathmin expression associates with vascular and immune responses in aggressive breast cancer subgroups
por: Askeland, Cecilie, et al.
Publicado: (2020)

Expression of Nestin associates with BRCA1 mutations, a basal-like phenotype and aggressive breast cancer
por: Krüger, Kristi, et al.
Publicado: (2017)

Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma
por: Ladstein, Rita G, et al.
Publicado: (2010)

Hypoxia induced responses are reflected in the stromal proteome of breast cancer
por: Kjølle, Silje, et al.
Publicado: (2023)

A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasms
por: Khan, M S, et al.
Publicado: (2013)

Mitotic count can predict tamoxifen benefit in postmenopausal breast cancer patients while Ki67 score cannot
por: Beelen, Karin, et al.
Publicado: (2018)

Ki-67 acts as a biological surfactant to disperse mitotic chromosomes
por: Cuylen, Sara, et al.
Publicado: (2016)

A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis
por: Fuchs, Talia L., et al.
Publicado: (2020)

Vessel size as a marker of survival in estrogen receptor positive breast cancer
por: Milosevic, Vladan, et al.
Publicado: (2023)

Ki-67 is a PP1-interacting protein that organises the mitotic chromosome periphery
por: Booth, Daniel G, et al.
Publicado: (2014)

Robust linear regression model of Ki-67 for mitotic rate in gastrointestinal stromal tumors
por: KEMMERLING, RALF, et al.
Publicado: (2014)

Assessment of Ki67 in Breast Cancer: A Comparison Between the Eye-10 Method, Stepwise Counting Strategy, and International System of Ki67 Evaluation
por: Kadivar, Maryam, et al.
Publicado: (2020)

The Ki-67 and RepoMan mitotic phosphatases assemble via an identical, yet novel mechanism
por: Kumar, Ganesan Senthil, et al.
Publicado: (2016)

Thyroid transcription factor-1 positive primary breast cancer: a case report with review of the literature
por: Klingen, Tor A, et al.
Publicado: (2010)

Ki-67 Expression in CRC Lymph Node Metastasis Does Not Predict Survival
por: Martins, Sandra F., et al.
Publicado: (2015)

Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas
por: Duregon, Eleonora, et al.
Publicado: (2016)

Can Histological Grade and Mitotic Index Replace Ki67 to Determine Luminal Breast Cancer Subtypes?
por: Oddó, David, et al.
Publicado: (2018)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

Integrin α11β1 is expressed in breast cancer stroma and associates with aggressive tumor phenotypes
por: Smeland, Hilde Ytre‐Hauge, et al.
Publicado: (2019)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

The Clinical Significance of Lymph Node Ratio and Ki-67 Expression in Papillary Thyroid Cancer
por: Lindfors, Helene, et al.
Publicado: (2021)

An interobserver reproducibility analysis of size-set semiautomatic counting for Ki67 assessment in breast cancer
por: Wang, Yi-xing, et al.
Publicado: (2019)

Sinonasal adenoid cystic carcinoma following formaldehyde exposure in the operating theatre
por: Sandvik, Anniken, et al.
Publicado: (2014)

Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis
por: Fluge, Ø, et al.
Publicado: (2009)

Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

The p150N domain of chromatin assembly factor-1 regulates Ki-67 accumulation on the mitotic perichromosomal layer
por: Matheson, Timothy D., et al.
Publicado: (2017)

Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma
por: Rossi, L, et al.
Publicado: (2015)

Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumors
por: Manem, Venkata S.K., et al.
Publicado: (2021)

The intrinsically disorderly story of Ki-67
por: Remnant, Lucy, et al.
Publicado: (2021)

Conversion of ER, PR, HER2 and Ki-67 and Prognosis in breast cancer metastases to the brain
por: Jiaxin, Chen, et al.
Publicado: (2022)

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
por: Fasanella, S, et al.
Publicado: (2011)

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
por: Nielsen, Torsten O, et al.
Publicado: (2020)

Addendum: Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumors
por: Manem, Venkata S.K., et al.
Publicado: (2022)

Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancer
por: Stefansson, Ingunn M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_apv707i60lu855t12m05s8dtp8